Iodoacetamide blank compensation in FXIII functional assays: Is it still necessary?
- PMID: 37293692
- DOI: 10.1111/ijlh.14111
Iodoacetamide blank compensation in FXIII functional assays: Is it still necessary?
References
REFERENCES
-
- Bouttefroy S, Meunier S, Milien V, et al. Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort. Br J Haematol. 2020;188(2):317-320. doi:10.1111/bjh.16133
-
- Kohler HP, Ichinose A, Seitz R, Ariens RA, Muszbek L, Factor XIII and Fibrinogen SSC Subcommittee of The ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost. 2011;9(7):1404-1406. doi:10.1111/j.1538-7836.2011.04315.x
-
- Katona É, Pénzes K, Molnár É, Muszbek L. Measurement of factor XIII activity in plasma. Clin Chem Lab Med. 2012;50(7):1191-1202. doi:10.1515/cclm-2011-0730
-
- Muszbek L, Katona É, Kerényi A. Assessment of factor XIII. Methods Mol Biol. 2017;1646:277-293. doi:10.1007/978-1-4939-7196-1_22
-
- Bovet J, Hurják B, De Maistre E, Katona É, Pénzes K, Muszbek L. Autoimmune factor XIII deficiency with unusual laboratory and clinical phenotype. J Thromb Haemost. 2020;18(6):1330-1334. doi:10.1111/jth.14811
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources